19
person
Members of FasterCures Changemakers
Randy Beranek
CEO, National Psoriasis Foundation
Kathy Giusti
Executive Chairman, Multiple Myelom
a Research Foundation
Michael Kaplan
President and CEO, Melanoma Research Alliance
+ Read More
staff
Kristin Schneeman
Kristin Schneeman joined FasterCures in April 2005, with primary responsibility for its innovatio
n portfolio of projects and activities.
+ Read More
panel
FasterCures Private Dinner (Invite only)
An intimate dinner for "friends of FasterCures," including our VIP delegation of the Advisory Bo
ard, Nonprofit Council, Business Council and TRAIN members.
+ Read More
panel
FasterCures Advisory Groups Meeting (Invite only)
This session will bring together the FasterCures Advisory Board, Business Council, Nonprofit Cou
ncil, and Senior Fellows. Programmatic updates will be discussed and upcoming key events will be flagged for the engagement of all groups.
+ Read More
panel
FasterCures Advisory Groups Meeting (Invite only)
This session will bring together the FasterCures Advisory Board, Business Council, Nonprofit Cou
ncil, and Senior Fellows. Programmatic updates will be discussed and upcoming key events will be flagged for the engagement of all groups.
+ Read More
staff
Valerie Barton
Valerie Barton, M.A.
panel
FasterCures Private Meeting (Invite only)
panel
FasterCures Private Meeting (Invite only)
panel
Health Data and Technology Accelerating Medical Research (Invite only)
As more technology companies enter the health space, their tools and services offer newfound pot
ential to accelerate medical research and help patients better manage and understand their own health through data-driven insights.
+ Read More
panel
COVID-19 Presses the Accelerator on Biomedical R&D
COVID-19 has exposed many fault lines that FasterCures identifies as brakes on progress in biome
dical R&D even in the best of times.
+ Read More
report
Recommendations to Advance Telehealth during and after the COVID-19 Pandemic
The use of telehealth services has expanded dramatically since the onset of COVID-19, driven by nec
essity and enabled by emergency changes to the policy landscape.
+ Read More